Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma DOI

Yi-Ting Hu,

Zhongfei Luo,

Siyi Cai

и другие.

Scandinavian Journal of Gastroenterology, Год журнала: 2024, Номер 59(6), С. 730 - 736

Опубликована: Март 1, 2024

Background Hepatocellular carcinoma (HCC) is the most malignant cancer worldwide. Sorafenib (SRF) a common therapeutic drug used for patients with advanced HCC. Nevertheless, resistance frequently occurs in treated sorafenib. Glycyrrhizic acid (GRA) natural compound that identified to exhibit anti-cancer effects. In this work, we aimed investigate effects of GRA on SRF-resistant HCC cells and potential regulatory mechanisms.

Язык: Английский

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT DOI Creative Commons
Jianing Tang,

Guo Long,

Kuan Hu

и другие.

Advanced Science, Год журнала: 2023, Номер 10(33)

Опубликована: Окт. 22, 2023

Hepatocellular carcinoma (HCC) is a lethal and aggressive human malignancy. The present study examins the anti-tumor effects of deubiquitylating enzymes (DUB) inhibitors in HCC. It found that inhibitor ubiquitin specific peptidase 8 (USP8) DUB-IN-3 shows most effective anti-cancer responses. Targeting USP8 inhibits proliferation HCC induces cell ferroptosis. In vivo xenograft metastasis experiments indicate inhibition suppresses tumor growth lung metastasis. treatment or depletion decrease intracellular cystine levels glutathione biosynthesis while increasing accumulation reactive oxygen species (ROS). Mechanistical studies reveal stabilizes O-GlcNAc transferase (OGT) via inhibiting K48-specific poly-ubiquitination process on OGT protein at K117 site, STE20-like kinase (SLK)-mediated S716 phosphorylation required for interaction with OGT. Most importantly, O-GlcNAcylates solute carrier family 7, member 11 (SLC7A11) Ser26 cells, which essential SLC7A11 to import from extracellular environment. Collectively, this demonstrates pharmacological knockout can inhibit progression induce ferroptosis decreasing stability OGT, imposes great challenge targeting potential approach treatment.

Язык: Английский

Процитировано

45

Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications DOI Creative Commons
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi

и другие.

Cancer Gene Therapy, Год журнала: 2024, Номер 31(8), С. 1105 - 1112

Опубликована: Март 18, 2024

Abstract Hepatocellular Carcinoma (HCC) is one of the most common types primary liver cancer. Current treatment options have limited efficacy against this malignancy, primarily owing to difficulties in early detection and inherent resistance existing drugs. Tumor heterogeneity a pivotal factor contributing significantly recurrent manifestations HCC. Intratumoral an important aspect spectrum complex tumor contributes late diagnosis failure. Therefore, it crucial thoroughly understand molecular mechanisms how develops. This review aims summarize possible dimensions with emphasis on intratumoral heterogeneity, evaluate its profound impact therapeutic strategies for HCC, explore suitability appropriate pre-clinical models that can be used best study heterogeneity; thus, opening new avenues cancer treatment.

Язык: Английский

Процитировано

39

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study DOI Open Access

Elias Kouroumalis,

Panagiotis Skordilis,

Kyriaki Thermos

и другие.

Gut, Год журнала: 1998, Номер 42(3), С. 442 - 447

Опубликована: Март 1, 1998

Background —Standard treatment of inoperable hepatocellular carcinoma has not been established. Somatostatin shown to possess antimitotic activity against a variety non-endocrine tumours. Aims —To assess the presence somatostatin receptors in human liver and treat advanced with analogue, octreotide. Methods —Somatostatin were measured tissue homogenates from patients acute chronic hepatitis, cirrhosis, carcinoma. Fifty eight randomised receive either subcutaneous octreotide 250 μg twice daily, or no treatment. Groups comparable respect age, sex, Okuda classification, biochemistry virology. Results —Various amounts identified all including those Treated had an increased median survival (13 months versus four months, p=0.002, log rank test) cumulative rate at six 12 (75% 37%, 56% 13% respectively). Octreotide administration significantly reduced α fetoprotein levels months. When multivariable Cox’s proportional hazards model was fitted, variables associated were: administration, absence serum albumin, small clearly lower hazard (0.383) multivariate analysis. Conclusions —Octreotide improves is valuable alternative

Язык: Английский

Процитировано

290

CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis DOI Creative Commons
Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya

и другие.

Non-coding RNA Research, Год журнала: 2024, Номер 9(2), С. 277 - 287

Опубликована: Янв. 26, 2024

The intricate molecular landscape of cancer pathogenesis continues to captivate researchers worldwide, with Circular RNAs (circRNAs) emerging as pivotal players in the dynamic regulation biological functions. study investigates elusive link between circRNAs and Transforming Growth Factor-β (TGF-β) signalling pathway, exploring their collective influence on progression metastasis. Our comprehensive investigation begins by profiling circRNA expression patterns diverse types, revealing a repertoire intricately linked TGF-β pathway. Through integrated bioinformatics analyses functional experiments, we elucidate specific circRNA-mRNA interactions that modulate signalling, unveiling regulatory controls governing this crucial Furthermore, provide compelling evidence impact circRNA-mediated modulation key cellular processes, including epithelial-mesenchymal transition (EMT), migration, cell proliferation. In addition mechanistic roles, have shown promise diagnostic prognostic biomarkers, well potential targets for therapy. Their ability critical pathways, such axis, underscores significance biology clinical applications. interplay is dissected, uncovering novel circuits contribute complexity biology. This review unravels previously unexplored dimension carcinogenesis, emphasizing role shaping landscape.

Язык: Английский

Процитировано

18

Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study DOI Creative Commons
Jingyi Tang,

Shengke Zhang,

Lai Jiang

и другие.

Journal of Cancer, Год журнала: 2024, Номер 15(13), С. 4219 - 4231

Опубликована: Янв. 1, 2024

Hepatocellular carcinoma (HCC), the predominant malignancy of digestive tract, ranks as third most common cause cancer-related mortality globally, significantly impeding human health and lifespan. Emerging immunotherapeutic approaches have ignited fresh optimism for patient outcomes. This investigation probes link between 731 immune cell phenotypes HCC through Mendelian Randomization single-cell sequencing, aiming to unearth viable drug targets dissect HCC's etiology.

Язык: Английский

Процитировано

14

Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer DOI

Junjun Jia,

Xuelian Zhou,

Qingfei Chu

и другие.

Molecular and Cellular Biochemistry, Год журнала: 2024, Номер 480(1), С. 1 - 17

Опубликована: Март 22, 2024

Язык: Английский

Процитировано

12

Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies DOI

Lu-Qi Cao,

Yuhao Xie, Joshua S. Fleishman

и другие.

Cancer Letters, Год журнала: 2024, Номер 597, С. 217061 - 217061

Опубликована: Июнь 13, 2024

Язык: Английский

Процитировано

12

Low-grade Chronic Inflammation: A Shared Mechanism for Chronic Diseases DOI
Mariana Cifuentes, Hugo Verdejo, Pablo Castro

и другие.

Physiology, Год журнала: 2024, Номер 40(1), С. 000 - 000

Опубликована: Июль 30, 2024

Inflammation is an important physiological response of the organism to restore homeostasis upon pathogenic or damaging stimuli. However, persistence harmful trigger a deficient resolution process can evolve into state low-grade, chronic inflammation. This condition strongly associated with development several increasingly prevalent and serious conditions, such as obesity, cancer, cardiovascular diseases, elevating overall morbidity mortality worldwide. The current pandemic diseases underscores need address inflammation, its mechanisms, potential preventive measures limit widespread impact. present review discusses knowledge research gaps regarding association between low-grade inflammation focusing on digestive cancer. We examine art in selected aspects topic propose future directions approaches for field.

Язык: Английский

Процитировано

11

Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin DOI Creative Commons

Henglai Sun,

Jijuan Nai,

Biqi Deng

и другие.

Molecules, Год журнала: 2024, Номер 29(3), С. 731 - 731

Опубликована: Фев. 5, 2024

The present work aimed to study the feasibility of Angelica sinensis polysaccharide (ASP) as an instinctive liver targeting drug delivery carrier for oridonin (ORI) in treatment hepatocellular carcinoma (HCC). ASP was reacted with deoxycholic acid (DOCA) via esterification reaction form ASP-DOCA conjugate. ORI-loaded nanoparticles (ORI/ASP-DOCA NPs) were prepared by thin-film water method, and their size about 195 nm aqueous solution. ORI/ASP-DOCA NPs had a loading capacity up 9.2%. release ORI pH-dependent, resulting rapid decomposition accelerated at acidic pH. significantly enhanced accumulation tumors through ASGPR-mediated endocytosis. In vitro results showed that increased cell uptake apoptosis HepG2 cells, vivo caused effective tumor suppression H22 tumor-bearing mice compared free ORI. short, might be simple, feasible, safe nano-drug system could used targeted tumors.

Язык: Английский

Процитировано

10

The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells DOI Creative Commons

Minghao Sui,

Tiantian Liu,

Xinyue Song

и другие.

Pharmacological Research, Год журнала: 2025, Номер unknown, С. 107619 - 107619

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

2